Mark Alles

Provides pharmaceutical research and biotechnology services

Operates as a trade association which promotes pharmaceutical discovery and development

The private company is based in Bridgewater, NJ. The HealthCare Institute of New Jersey (HINJ) is a trade association representing research-based biopharmaceutical and medical technology companies. It advocates for policies that expand patient access to medicines, medical devices, vaccines, and diagnostics, and promotes value-based healthcare and fair drug pricing. HINJ supports legislation on antimicrobial resistance and diagnostic regulation modernization, monitors policy to foster a competitive life sciences ecosystem, and emphasizes corporate social responsibility, including philanthropy, community engagement, environmental sustainability, and employee volunteerism. The organization advances diversity, equity, and inclusion initiatives, collaborates with government, academia, and industry partners, and administers patient assistance programs such as the Rx4NJ partnership and promotes awareness of NJSAVE. Christine Buteas has been the CEO of the company since 2024.

Provides support services to cancer patients

Develops pharmaceutical technology

Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies

Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases

Develops CAR-T therapy platform for cancer therapies

Operates as a biopharmaceutical company which develops and commercializes hematologic malignancies therapies

Develops AI powered protein therapeutics discovery platform

Operates as a clinical-stage biopharmaceutical company that develops antibody-based medicines for cancer patients